Tight binding enantiomers of pre-clinical drug candidates
Journal Article
·
· Bioorgan. Med. Chem.
- Einstein
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- NIHFOREIGN
- OSTI ID:
- 1221447
- Journal Information:
- Bioorgan. Med. Chem., Vol. 23, Issue (17) ; 09, 2015
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Tight binding enantiomers of pre-clinical drug candidates
Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and /sup 3/H FMLP binding. Effect of sulindac sulfide, indomethacin metabolite, and optical enantiomers (+) and (-) MK830
Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Journal Article
·
Tue Sep 01 00:00:00 EDT 2015
· Bioorganic and Medicinal Chemistry
·
OSTI ID:1221447
+5 more
Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and /sup 3/H FMLP binding. Effect of sulindac sulfide, indomethacin metabolite, and optical enantiomers (+) and (-) MK830
Journal Article
·
Mon Mar 01 00:00:00 EST 1982
· Inflammation (N.Y.); (United States)
·
OSTI ID:1221447
+3 more
Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Journal Article
·
Mon Mar 27 00:00:00 EDT 2017
· Journal of Medicinal Chemistry
·
OSTI ID:1221447
+46 more